Clinical Trial Update: Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue [Phase 1]

View source ↗

Summary

Phase 1 study assessing gepotidacin penetration into prostate and tonsillar tissue has completed, providing pharmacokinetic tissue data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonorrhea

Drugs mentioned

• Gepotidacin (gepotidacin)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Gonorrhea, Infection, Bacterial | Phase 1 | Status: COMPLETED